Krakow, Poland – July 13, 2017 – Institute of Hematology and Transfusion Medicine, the leading Polish hematology and blood transfusion institute, jointly with Selvita, a clinical stage drug discovery and development company focused on innovative medicines for oncology patients, have published results of a research projects concerning therapeutic potential of…
Selvita presents at 18th Drug Discovery Summit in Berlin
Krakow, Poland – 06 June 2017 – Selvita is a proud sponsor of the upcoming 18th Drug Discovery Summit which will take place on June 12 – 13, 2017, in Berlin, Germany. This event will gather over 250 delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions,…
Selvita participates in BIO Convention
Kraków, Poland – 01 June 2017 – Selvita will participate in the upcoming Annual BIO International Convention, taking place on June 19-22, 2017, at the San Diego Convention Center, CA, USA. BIO Convention is the largest, most influential biotech Convention in the world. This event offers an unprecedented chance to…
Selvita doubles the revenue in Q1 2017 vs. Q1 2016
Krakow, Poland – May 31, 2017 – Selvita, one of the largest drug discovery company in Europe, has generated a very strong revenue growth in the first quarter of 2017. In Q1 2017 Selvita Group recognized total operating revenues (incl. grants) in the amount of PLN 26.8 MM, which means…
Selvita opens new research site in Poznan
Krakow, Poland – 10 May 2017 – Selvita (WSE:SLV), one of the largest drug discovery companies in Europe, has opened a new research site in Poznan, Poland. The new site is located in the Wielkopolska Centre of Advanced Technologies and the initial laboratory space which Selvita occupies amounts to 5…
Selvita shows 19% business growth in 2016
Krakow, Poland – 20 April 2017 – Selvita, one of the largest drug discovery companies in Europe, has published annual financial results demonstrating its continued dynamic business performance across all segments. Net sales revenue in 2016 (excl. grants) amounted to PLN 48.1 MM, reflecting 17% growth compared with 2015, when…